StockWatch
·

JTL Industries Ltd Q2 FY27 Results

JTLINDQ2 FY27 Results
Filing
Result:Good· Market: Flat#Margin expansion#Margin squeeze

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue613.7914.9%43.0%
Total Income617.0915.0%43.1%
Expenditure577.5414.8%44.2%
PBT39.5518.3%28.9%
Net Profit28.9718.1%30.7%
OPM8.27%0.13pp0.20pp
NPM4.69%0.18pp0.45pp
EPS0.6428.9%14.3%
View full financials

Revenue +43% YoY on 25% volume growth with operating margin expanding to 8.27% (above the ₹4,500+/ton target) and adjusted PAT growth of ~43%, but net margin compressed to 4.72% as finance costs and depreciation from the JTL Defence consolidation ate into the bottom line, keeping this a solid but not standout quarter.

JTLIND · Q2 FY27 · THE VERDICT

Margin beat, volume miss — execution watch

JTL Industries beat on EBITDA per ton but missed its volume growth target. The gap is the quarter — and the H2 ramp that now determines whether the full-year 30% target survives.

11 Nov 2026 · 6 min read
Volume growth YoY

23.2%

Q2 actual vs 30% prior target

EBITDA/ton

₹5,053

Beat ₹4,500 target by 12%

Capex H1

₹76.5 Cr

FY27 trajectory ₹200-225 Cr vs ₹100 Cr prior

WC cycle

83 days

vs Q1 75, vs target 60 by FY28

JTL Industries filed exactly what it promised — ₹613.8 Cr in revenue and ₹29 Cr in profit — but the numbers mask a quarter defined by two competing truths. Management beat on unit margins by 12% (EBITDA per ton ₹5,053 vs the ₹4,500+ target set in Q1), driven by a sharp mix shift toward value-added products. But it missed its volume growth target by nearly 7 percentage points (Q2 came in 23.2% YoY, down from the 30% YoY guidance set at the start of the year). Half a year in, the company is now betting on a very aggressive H2 ramp — needing 2.96L tons sequentially to hit the full-year 30% target — dependent on new capacity coming online in untested conditions.

The quarter in numbers: margin quality, volume risk

The reported profit of ₹29 Cr includes a ₹2.78 Cr one-time depreciation charge from the JTL Defence revaluation (a non-cash item from March 2026). Normalized PAT would be ₹31.8 Cr — a minor adjustment, since the real story is not hidden in the financials but in the shape of the quarter.

Management's guidance vs. what delivered

Volume growth 30% YoY

Q2: 23.2% YoY. H1: 20.2% YoY.

Contradicted

EBITDA per ton ₹4,500+

Q2: ₹5,053. H1: ₹5,000.

Supported (+12%)

Export 10% of sales (revised from 15%)

H1: 12k tons on 2.19L volume = 5.5%. FY27 target 50-55k on 5.15L ≈ 10%.

On track (but H1 behind pace)

FY27 capex ₹100 Cr for 2MT capacity

H1: ₹76.5 Cr. H2 guidance: ₹125-150 Cr. Total ≈ ₹200-225 Cr.

Doubled (unannounced)

GP line commissioning (capacity ramp Q3-Q4)

Cold trials complete Q2; commercial Q3 start, 25-30k tons Q4.

Supported (on timeline)

What changed on this call

  • Capex doubled to ₹200-225 Cr FY27 (vs ₹100 Cr prior) — not called as a change; buried in Q&A

  • Volume growth target now rides on H2 execution: H2 needs +38% sequential (2.96L vs H1 2.19L)

  • EBITDA/ton ceiling raised: ₹4,500 → ₹5,053 beat; FY28 now ₹5,000-5,250 (vs maintenance at ₹4,500)

  • Working capital deteriorated Q1→Q2 (75 days → 83 days); target path extended to 60 days FY28, 35 days FY29

  • Export target revised: new markets (US, Canada) opened; trial orders accepted. Container constraints cited as material headwind.

  • Defence revenue trajectory extended: ₹150 Cr near-term unattainable; now phased to 1k tons/month by FY29 (≈ ₹200+ Cr run-rate)

The bull-bear ledger

Why hold (not buy or sell)
  • EBITDA per ton beats prior target by 12%, driven by mix shift (VAP 27.9% → target 50% next FY)

  • Operating cash flow turned positive: ₹50 Cr H1 (vs ₹80.3 Cr outflow prior year), despite capex

  • H1 all-time high: 2.19L MT volume, ₹1,335 Cr revenue, ₹109.5 Cr EBITDA. Domestic secondary-coil demand robust.

  • Volume growth 7pp below prior target (23.2% vs 30%); H2 ramp depends on unproven capacity commissioning in monsoon/supply-constrained environment

  • Working capital cycle worsened and now misses intermediate targets: Q2 83 days vs Q1 75 days; prior said 60 by FY28

  • Capex doubled without re-guidance; if H2 slips further, debt/equity and dividend capacity at risk

  • Export volumes H1 only 12k tons (5.5%) vs target 50-55k FY27; dependent on volatile container availability and Hormuz strait stability

Risks, ranked by severity

The execution concerns that matter most

Capacity ramp-up execution (GP line Q3, colour-coated Dec, CRM complex Q3-Q4)

High

Cold trials done, but monsoon, material delays, electricity connection cited. Slippage cascades to H2 volume miss → full-year 30% target unattainable.

Volume growth target at execution risk

High

Q2 and H1 both missed 30% YoY. H2 needs +38% sequential (2.96L vs 2.19L H1) — heavily dependent on GP/colour-coated ramp coming on time and performing.

Export dependency on container/geopolitics

Medium

H1 only 12k tons (5.5% of volume) vs 50-55k FY target (10%). New US/Canada markets in trial phase. Container availability described as 'quite dynamic'; Hormuz closure ongoing.

Working capital deterioration + path uncertainty

Medium

Q2 worsened to 83 days (vs Q1 75). Government sales still 20% (target <10%); vendor finance scheme untested. Target 60 days FY28 now looks ambitious.

Capex overrun / capital intensity surge

Medium

FY27 capex doubled from ₹100 Cr to ₹200-225 Cr (unannounced). FY28 ₹115-125 Cr (maintenance + API). Debt/equity, dividend capacity at risk if further slippage.

Defence revenue trajectory extended; still minimal contribution

Low-Medium

Prior ₹150 Cr FY27 target now unattainable. Q2 only 356 tons (~₹2-3 Cr revenue). Ramp to 1k tons/month by FY29 is early-stage, execution unproven.

How the street is positioned

Price action & valuation: The stock closed at ₹76.64, sitting below both its 20-day (₹77.95) and 50-day (₹83.98) averages, but above the 200-day (₹73.37). It is trading 44.86% below its all-time high but up 90.41% off the 52-week low — a recovery move that has lost momentum. The RSI of 45.5 signals neutral positioning. Importantly, the stock did not pop on the earnings print; the market is withholding conviction.

Ownership shifts: Foreign portfolio investors (FPI) added 1.44 percentage points quarter-over-quarter, reaching 4.84% of equity (vs 3.40% in the prior quarter). This is a modest increase and suggests cautious inching into the stock, not conviction buying. Domestic institutional interest is minimal (DII 0.14% in Q1 FY27, up from 0% in the prior quarter). Promoter holding remains stable at 49.26%.

Bulk activity: A bulk purchase by F3 Advisors Private Limited at ₹79.30 (20.52 million shares) signals that someone with deep pockets sees value at a 3% premium to current levels. This is a positive signal — a real buyer, not a forced seller — but the lack of insider/promoter activity near current levels rules out management signaling conviction.

The market's view: measured recovery, not conviction. The stock has clawed back 90% of its year-to-date drawdown, but the post-result price action was flat (no pop, no fade). The modest FPI inching and bulk buying at ₹79 suggest the street sees a 'show me' setup — good margins and new capacity are valuable, but execution on volume and capital discipline is the gate. The 44% discount from the all-time high reflects residual caution on the capex cycle and commodities leverage.

The debate

What to watch next
  • 1 · Q3 capacity ramp-up pace (GP line, colour-coated line commissioning)

    Cold trials are done, but the calendar is tight. Monsoon and supply constraints were cited. Any delay cascades to H2. The number to track: combined run-rate from GP and colour-coated (current 40k tons/month; target 50-65k by year-end).

  • 2 · Volume trajectory in H2 (the 30% FY target gate)

    H1 came in 20.2% YoY. H2 needs +38% sequential to hit 30% full-year. This is the acid test. If H2 comes in at +25-30% sequential, the full-year target slips to 27-28% (still solid, but a miss vs guidance).

  • 3 · Working capital cycle trajectory (target 60 days FY28)

    Q2 was 83 days vs Q1 75 days — deterioration, not improvement. Government sales (20%) are the drag. Watch Q3 for any evidence of dealer shift or vendor finance scheme impact. If WC stays in the 80-85 day range through Q3, the FY28 60-day target looks unattainable.

JTL Industries is executing a margin-expansion and capacity-build strategy that is fundamentally sound. But the quarter revealed execution risk on volume, capital discipline, and working capital that the market was underpricing. The stock's flat post-result action (no pop despite strong margins) suggests the street has already priced in a 'show me' stance.

Hold the stock for margin quality and new capacity upside, but watch H2 execution closely. If Q3 delivers on capacity ramp and export volumes start to climb, the bear case weakens and the stock re-rates higher. If H2 disappoints on volume or capex, the stock mean-reverts. The single number to track: volume growth in H2 (target 2.96L tons to hit 30% FY growth). That is the gate.

Informational and educational content only. Not investment advice.